John R Mascola

USPTO Granted Patents = 45 (Patent Applications = 19)

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 5 (Patent Applications = 17)

Average Co-Inventor Count = 9.4

ph-index = 5

Forward Citations = 78(Granted Patents)

Company Filing History:

43 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

4 out of 2,103

University of Washington

patents

4 out of 68

International Aids Vaccine Initiative

patents

4. 3 out of 1,209

Dana-farber-cancer Institute Inc.

patents

5. 3 out of 1,929

University System of Maryland

University of Pennsylvania

Leland Stanford Junior University

Institute for Research in Biomedicine

patents

12. 2 out of 1,187

The Scripps Research Institute

patents

13. 1 out of 575

Los Alamos National Security, LLC

patents

14. 1 out of 1

The United States of America, As Represented by

patent

15. 1 out of 288

Triad National Security, LLC

patents

16. 1 out of 1

Centre for the Aids Programme of Research in South Africa

patent

17. 1 out of 36

University of the Witwatersrand, Johannesburg

patents

18. 1 out of 3

National Health Laboratory Service

patents

19. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

HIV-1 Antibodies

Influenza Hemagglutinin

Prefusion Immunogens

Multispecific Antibodies

Recombinant Envelope Proteins

Zika Virus Vaccines

Self-Assembling Nanoparticles

Broadly Neutralizing Antibodies

Middle East Respiratory Syndrome

Glycan-Masked Proteins

CD4-Mimetic Inhibitors

Antibody Evolution Immunogens

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435113 - Prefusion PIV F immunogens and their use (2025-10-07),

2. 12365722 - Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope (2025-07-22),

3. 12275758 - Prefusion RSV F proteins and their use (2025-04-14),

4. 12268737 - Stabilized influenza hemagglutinin stem region trimers and uses thereof (2025-04-08),

5. 12053520 - Glycan-masked engineered outer domains of HIV-1 gp120 and their use (2024-08-06),

6. 11969466 - Stabilized influenza hemagglutinin stem region trimers and uses thereof (2024-04-30),

7. 11793871 - Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof (2023-10-24),

8. 11679151 - Stabilized influenza hemagglutinin stem region trimers and uses thereof (2023-06-20),

9. 11602559 - HIV-1 Env fusion peptide immunogens and their use (2023-03-14),

10. 11459360 - Recombinant HIV-1 envelope proteins and their use (2022-10-04),

11. 11338033 - Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof (2022-05-24),

12. 11236152 - Neutralizing antibodies to HIV-1 GP41 and their use (2022-02-01),

13. 11235056 - Glycan-masked engineered outer domains of HIV-1 gp120 and their use (2022-02-01),

14. 11174292 - Substitutions-modified prefusion RSV F proteins and their use (2021-11-16),

15. 11149082 - Multispecific antibodies targeting human immunodeficiency virus and methods of using the same (2021-10-19),

Title: The Innovative Journey of John R Mascola

Introduction: John R Mascola, a distinguished inventor hailing from Rockville, MD, has made significant contributions to the field of technology and innovation.

Latest Patents: John R Mascola's latest patents focus on cutting-edge advancements in biotechnology, including novel methods for drug delivery and innovative medical devices.

Career Highlights: With a career spanning over two decades, John R Mascola has established himself as a visionary in the realm of inventing. His groundbreaking work has led to numerous patents that have revolutionized the healthcare industry.

Collaborations: Throughout his career, John R Mascola has collaborated with leading researchers, scientists, and industry experts to bring his inventions to life. His ability to work in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: John R Mascola's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventing. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

This text is generated by artificial intelligence and may not be accurate.